VAPOTHERM INC·4

Sep 13, 4:25 PM ET

Dube Joel F. 4

4 · VAPOTHERM INC · Filed Sep 13, 2021

Insider Transaction Report

Form 4
Period: 2021-09-10
Dube Joel F.
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-09-104164,584 total
    Exercise: $12.16Exp: 2030-01-01Common Stock (416 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-09-105806,420 total
    Exercise: $12.28Exp: 2030-01-20Common Stock (580 underlying)
  • Exercise/Conversion

    Common Stock

    2021-09-10$12.16/sh+416$5,0594,516 total
  • Sale

    Common Stock

    2021-09-10$29.10/sh996$28,9844,100 total
  • Exercise/Conversion

    Common Stock

    2021-09-10$12.28/sh+580$7,1225,096 total
Footnotes (3)
  • [F1]Includes 4,100 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan.
  • [F2]This option is eligible to vest as to 25% of the underlying shares on January 1, 2021, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Company's applicable equity incentive plan.
  • [F3]This option is eligible to vest as to 25% of the underlying shares on December 2, 2020, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, provided that the Reporting Person continues to serve as an employee or other service provider to the Issuer on each vesting date and otherwise subject to the Company's applicable equity incentive plan.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT